IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 59 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,889,975 | -3.1% | 113,487 | +11.9% | 0.00% | 0.0% |
| Q2 2023 | $6,081,023 | +84.8% | 101,418 | +52.4% | 0.00% | +50.0% |
| Q1 2023 | $3,291,023 | -10.2% | 66,566 | +4.8% | 0.00% | 0.0% |
| Q4 2022 | $3,665,738 | +36.8% | 63,542 | +8.7% | 0.00% | 0.0% |
| Q3 2022 | $2,679,027 | +242.4% | 58,443 | +168.2% | 0.00% | +100.0% |
| Q2 2022 | $782,369 | +20.9% | 21,793 | 0.0% | 0.00% | – |
| Q1 2022 | $647,252 | – | 21,793 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |